NCT00184756 Efficacy on Height in SGA Children Treated With Growth Hormone Status COMPLETED Phase PHASE3
NCT00184743 Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) Status COMPLETED Phase PHASE3
NCT00184730 Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) Status COMPLETED Phase PHASE3
NCT00184717 Growth Hormone Treatment in Children Born Small for Gestational Age (SGA) Status COMPLETED Phase PHASE3
NCT00184691 Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years Status COMPLETED Phase PHASE3
NCT00184678 Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency Status COMPLETED Phase PHASE3
NCT00184665 Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT00184652 Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease Status COMPLETED Phase PHASE2
NCT00184639 Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT00184626 Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. Status COMPLETED Phase PHASE4
NCT00184613 Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT00184600 Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00184574 Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00184561 Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00184548 Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Status TERMINATED Phase PHASE3
NCT00154427 Use of Activated Recombinant Human Factor VII in Cardiac Surgery Status TERMINATED Phase PHASE2